NOVAVAX INC - COM (NVAX)

CUSIP: 670002104

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
126,789,755
Share change
+11,280,028
Total reported value
$157,221,076
Put/Call ratio
83%
Price per share
$1.24
Number of holders
130
Value change
+$14,084,196
Number of buys
59
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 670002104?
CUSIP 670002104 identifies NVAX - NOVAVAX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NOVAVAX INC - COM (NVAX) as of Q4 2017

As of 31 Dec 2017, NOVAVAX INC - COM (NVAX) was held by 130 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 126,789,755 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, BB BIOTECH AG, JPMORGAN CHASE & CO, FMR LLC, NORTHERN TRUST CORP, FRANKLIN RESOURCES INC, AMERIPRISE FINANCIAL INC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 130 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.